Cite
HARVARD Citation
Rubstov, D. et al. (n.d.). P545 Calprotectin at week 12 is a predictor for histological remission in ulcerative colitis patients treated with Vedolizumab. Journal of Crohn's and colitis. pp. S515-S516. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rubstov, D. et al. (n.d.). P545 Calprotectin at week 12 is a predictor for histological remission in ulcerative colitis patients treated with Vedolizumab. Journal of Crohn's and colitis. pp. S515-S516. [Online].